Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Effect of the Addition of Netarsudil 0.02% vs. Brimonidine 0.1% in Normal Tension Glaucoma Patients Currently on Latanoprost 0.005%

NCT06449352 is registered in ClinicalTrials.gov with Westlake Eye Specialists as lead sponsor.

NCT NCT06449352
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06449352 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Effect of the Addition of Netarsudil 0.02% vs. Brimonidine 0.1% in Normal Tension Glaucoma Patients Currently on Latanoprost 0.005%
Lead sponsor
Westlake Eye Specialists
Phase
Phase 4
Overall status
Completed
Start date
June 13, 2024
Completion date
September 22, 2025
Enrollment
100 (actual)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

normal tension glaucoma